





Alphabet’s Gemini 3.5 Pro is reported to be “months behind schedule,” putting pressure on its AI competitiveness versus OpenAI and Anthropic. The article flags coding capability delays and added U.S. government testing/approval steps, while noting heavy AI capex forecast to approach $187B this year versus ~$212B cash from operations—leaving only ~$25B in positive free cash flow (down from ~$73B last year). Alphabet shares slipped ~2% by 10:15 a.m. ET following the report, suggesting investors are starting to discount progress and ROI on AI spending.
This is less about one delayed model than about the market questioning whether Alphabet can still convert scale into frontier-AI advantage. If execution keeps slipping, the equity starts to trade like a mature platform funding a costly R&D arms race, which is a different multiple regime: lower confidence in long-run operating leverage and higher sensitivity to any capex disappointment.
The immediate loser is Alphabet's own optionality, but the second-order winners are the companies selling picks-and-shovels to everyone else in the race. A schedule slip at one lab does not reduce compute demand; it usually extends the spend cycle as rivals keep investing to avoid falling behind, which is structurally supportive for NVDA and adjacent infrastructure names over the next 6-18 months. The real strategic risk for Alphabet is not a single model miss, but gradual migration of high-value developer workflows toward competitors, which can leak into cloud, search monetization, and partner distribution over several quarters.
Contrarian view: the selloff may be larger than the near-term earnings impact because investors are extrapolating a product delay into a thesis collapse. That is premature unless next quarter shows both continued capex intensity and no measurable AI monetization lift. The thesis is falsified if Alphabet ships a materially better model on schedule and can show AI features raising engagement or revenue per query without another step-up in spend.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
mildly negative
Sentiment Score
-0.35
Ticker Sentiment